EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Growth factors and growth factor gene therapies for treating chronic wounds

James A Mullin iD, Erfan Rahmani, Kristi L Kiick, Millicent O Sullivan

Bioengineering & Translational Medicine · 2024-05 · 9 (3)

DOI: 10.1002/btm2.10642 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 28.12.2023. Verfasst von James A Mullin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering University of Delaware Newark Delaware USA. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic wounds are an unmet clinical need affecting millions of patients globally, and current standards of care fail to consistently promote complete wound closure and prevent recurrence. Disruptions in growth factor signaling, a hallmark of chronic wounds, have led researchers to pursue growth factor therapies as potential supplements to standards of care. Initial studies delivering growth factors in protein form showed promise, with a few formulations reaching clinical trials and one obtaining clinical approval. However, protein‐form growth factors are limited by instability and off‐target effects. Gene therapy offers an alternative approach to deliver growth factors to the chronic wound environment, but safety concerns surrounding gene therapy as well as efficacy challenges in the gene delivery process have prevented clinical translation. Current growth factor delivery and gene therapy approaches have primarily used single growth factor formulations, but recent efforts have aimed to develop multi‐growth factor approaches that are better suited to address growth factor insufficiencies in the chronic wound environment, and these strategies have demonstrated improved efficacy in preclinical studies. This review provides an overview of chronic wound healing, emphasizing the need and potential for growth factor therapies. It includes a summary of current standards of care, recent advances in growth factor, cell‐based, and gene therapy approaches, and future perspectives for multi‐growth factor therapeutics.

Schlagwörter

Stichwörter der Autor:innen

chronic woundsgene therapygrowth factors

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering University of Delaware Newark Delaware USA.
  • Department of Biomedical Engineering University of Delaware Newark Delaware USA.
  • Department of Materials Science and Engineering University of Delaware Newark Delaware USA.

ORCID-Profile: James A Mullin

Förderung

  • NIAMS NIH HHS
  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • Division of Chemical, Bioengineering, Environmental, and Transport Systems
  • Translational Impacts

Zitieren

APA

Mullin, J. A., Rahmani, E., Kiick, K. L., & Sullivan, M. O. (2024). Growth factors and growth factor gene therapies for treating chronic wounds. Bioengineering & Translational Medicine, 9(3). https://doi.org/10.1002/btm2.10642

Vancouver

Mullin JA, Rahmani E, Kiick KL, Sullivan MO. Growth factors and growth factor gene therapies for treating chronic wounds. Bioengineering & Translational Medicine. 2024;9(3). doi:10.1002/btm2.10642

BibTeX
@article{Mullin2024,
  author = {Mullin, James A and Rahmani, Erfan and Kiick, Kristi L and Sullivan, Millicent O},
  title = {Growth factors and growth factor gene therapies for treating chronic wounds},
  journal = {Bioengineering & Translational Medicine},
  year = {2024},
  volume = {9},
  number = {3},
  doi = {10.1002/btm2.10642}
}
Kostenlos starten →